Display Settings:

Format

Send to:

Choose Destination

    Am J Gastroenterol. 1989 Aug;84(8):888-91.

    Mouth-to-cecum transit time in patients affected by chronic constipation: effect of glucomannan.

    Marzio L, Del Bianco R, Donne MD, Pieramico O, Cuccurullo F.

    Istituto di Fisiopatologia Medica, Universita' di Chieti, Italy.

    Mouth-to-cecum transit time was studied in 13 patients affected by chronic idiopathic constipation and 18 control subjects matched with the constipation group for age, sex, and dietary habits. In a preliminary investigation, all patients showed a prolonged whole gut (oroanal) transit time as measured with radiopaque markers. Mouth-to-cecum transit time was studied through the serial determination of breath H2 after administration of 12 g lactulose diluted in 120 ml water. Breath H2 was measured with a gas analyzer and was determined in parts per million (ppm). Breath H2 after lactulose was also determined in the group with constipation after a 10-day diet that included either glucomannan (1 g tid orally) or placebo administered in a double-blind manner. The results show a statistically significant increase in mouth-to-cecum transit time in the group with constipation, compared with controls, and a return to within the normal range after the 10-day treatment with glucomannan. With placebo, no difference in transit time was noted. We therefore suggest that chronic idiopathic constipation is a disease that involves the whole gut.

    PMID: 2547312 [PubMed - indexed for MEDLINE]

    Supplemental Content

    Click here to read Click here to read

    Patient drug information

    • Lactulose (Cholac® Syrup, Constilac® Syrup, Constulose®, ...)

      Lactulose is a synthetic sugar used to treat constipation. It is broken down in the colon into products that pull water out from the body and into the colon. This water softens stools. Lactulose is also used to reduce th...